Adapting inpatient addiction medicine consult services during the COVID-19 pandemic |
Addiction Science & Clinical Practice |
Unintended Consequences of COVID-19 - Impact on Harms Caused by Substance Use |
Canadian Institute for Health Information |
Genetic Liability to Cannabis Use Disorder and COVID-19 Hospitalization |
Biological Psychiatry Global Open Science |
Genre et intervention en dépendance en contexte de pandémie auprès de personnes en situation de précarité sociale : le projet «GID-COVID» [Réponse rapide] (in French only) |
National Institute of Public Health in Quebec |
Impact of the COVID-19 pandemic on the pharmacological, physical, and psychological treatments of pain: findings from the Chronic Pain & COVID-19 Pan-Canadian Study |
Pain Reports |
Mental health and substance use during the COVID-19 Pandemic: Implications for healthcare |
Hospital News |
Overdose Prevention During a Pandemic |
Canadian Association of People who Use Drugs |
Relationship of substance dependence and time to RT-PCR negative status in patients with COVID-19 infection |
Asian Journal of Psychiatry |
Review of opioid risk assessment tools with the growing need for telemedicine |
Pain Management |
Screening and brief intervention for substance use disorders in times of COVID-19: potential opportunities, adaptations, and challenges |
American Journal of Drug and Alcohol Abuse |
Substance use and abuse, COVID-19-related distress, and disregard for social distancing: A network analysis |
Addictive Behaviors |
Take home injectable opioids for opioid use disorder during and after the COVID-19 Pandemic is in urgent need: a case study |
Substance Abuse Treatment, Prevention, and Policy |
The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review |
Substance Abuse Treatment, Prevention, and Policy |
Physician Health Care Visits for Mental Health and Substance Use During the COVID-19 Pandemic in Ontario, Canada |
JAMA Network Open |
Changes in Alcohol Consumption in Canada During the COVID-19 Pandemic: Associations With Anxiety and Self-Perception of Depression and Loneliness |
Alcohol and Alcoholism |
Alcohol and substance use in pregnancy during the COVID-19 pandemic |
Drug Alcohol Dependence |
A longitudinal approach to understanding risk factors for problem alcohol use during the COVID‐19 pandemic |
Alcoholism: Clinical and Experimental Research |
The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review |
Substance Abuse Treatment, Prevention, and Policy |
Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study |
Journal of Substance Abuse Treatment |
Differential impacts of COVID-19 across racial-ethnic identities in persons with opioid use disorder |
Journal of Substance Abuse Treatment |
Research Snapshot: The negative impacts of COVID-19 on people who use drugs in Canada |
Evidence Exchange Network |
Review of the adaptations in opioid agonist treatment during the COVID-19 pandemic: Focus on buprenorphine-based treatment |
Journal of Opioid Management |
Risk factors for elevations in substance use and consequences during the COVID-19 pandemic among sexual and gender minorities assigned female at birth |
Drug and Alcohol Dependence |
The impact of COVID-19 on gambling and gambling disorder: emerging data |
Current Opinions in Psychiatry |
Patients' perceptions of telehealth services for outpatient treatment of substance use disorders during the COVID-19 pandemic |
American Journal of Addictions |
Understanding the Impacts of Novel Coronavirus Outbreaks on People Who Use Drugs: A Systematic Review to Inform Practice and Drug Policy Responses to COVID-19 |
International Journal of Environmental Research and Public Health |
Assessing international alcohol consumption patterns during isolation from the COVID-19 pandemic using an online survey: highlighting negative emotionality mechanisms |
BMJ Open |
COVID-19-related social isolation stressors and their relationship to drinking behaviors in the general adult population |
The Dram |
Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada |
International Journal of Drug Policy |
Methadone Access for Opioid Use Disorder During the COVID-19 Pandemic Within the United States and Canada |
JAMA Network Open |
Is another public health crisis brewing beneath the COVID-19 pandemic? |
Canadian Journal of Public Health |
Study Results: In a Small Sample of Individuals with SUD, Many Are Hesitant to Receive Vaccine |
Addiction Policy Forum |
Substance use and abuse, COVID-19-related distress, and disregard for social distancing: A network analysis |
Addictive Behaviors |
Alcohol use disorder: A pre-existing condition for COVID-19? |
Alcohol |
COVID-19 - Infection Mitigation in Outpatient Settings |
American Society of Addiction Medicine |
COVID-19 - Infection Mitigation in Residential Treatment Facilities |
American Society of Addiction Medicine |
Screening and brief intervention for substance use disorders in times of COVID-19: potential opportunities, adaptations, and challenges |
American Journal of Drug and Alcohol Abuse |
Relationship of substance dependence and time to RT-PCR negative status in patients with COVID-19 infection |
Asian Journal of Psychiatry |
Overdose in the context of COVID-19 outbreak |
BCCDC Harm Reduction Services |
COVID-19: Harm Reduction and Overdose Response |
B.C.Centre for Disease Control |
COVID-19: Information for Opioid Agonist Treatment Prescribers and Pharmacists |
B.C. Centre on Substance Use |
Risk Mitigation in the Context of Dual Public Health Emergencies |
B.C. Centre on Substance Use |
COVID-19: Responding to Opioid Overdoses in Overdose Prevention Services (OPS) and Supervised Consumption Sites (SCS) |
BC Ministry of Health |
Strengthening Recovery During Crises: A four-part webinar series discussing addiction recovery amid public health crises |
British Columbia Centre on Substance Use |
Supporting Harm Reduction in COVID 19 Shelter and Self Isolation (webinar) |
Canadian Alliance to End Homelessness |
Virtual Care for Mental Health and Substance Use During COVID-19 [infographic] |
Canadian Centre on Substance Use and Addiction, Canadian Psychological Association, Canadian Society of Addiction Medicine, Mental Health Commission of Canada, The Royal |
How COVID-19 Is Changing Addiction Medicine: A Summary from the Canadian Society of Addiction Medicine–International Society of Addiction Medicine 2020 Conference |
Canadian Centre on Substance Use and Addiction, Canadian Society of Addiction Medicine |
Methamphetamine, the Respiratory System and COVID-19 [report] |
Canadian Centre on Substance Use and Addiction |
Methamphetamine, Cocaine and COVID-19 Health Risks [infographic] |
Canadian Centre on Substance Use and Addiction |
COVID-19 and Impaired Driving Risks (infographic) |
Canadian Centre on Substance Use and Addiction |
Getting Back on the Road: Relaxing of COVID-19 Measures and Impaired Driving Risks (infographic) |
Canadian Centre on Substance Use and Addiction |
COVID-19 and Cannabis Smoking and Vaping: Four Things You Should Know [report] |
Canadian Centre on Substance Use and Addiction |
COVID-19 and Cannabis Smoking: 4 Things You Should Know [infographic] |
Canadian Centre on Substance Use and Addiction |
COVID-19 and Cannabis: How to Reduce Your Risk [infographic] |
Canadian Centre on Substance Use and Addiction |
Managing Stress, Anxiety and Substance Use During Covid-19: A Resource for Healthcare Providers [infographic] |
Canadian Centre on Substance Use and Addiction and Mental Health Commission of Canada |
Rapid Review of the Impacts of “Big Events” On People Who Use Drugs and Delivery of Harm Reduction and Drug Treatment Services: Implications for Strengthening Systems in Response to COVID-19 |
Canadian Institutes of Health Research |
Impacts of COVID-19 on Youth Mental Health, Substance Use, and Well-being: A Rapid Survey of Clinical and Community Samples |
Canadian Journal of Psychiatry |
Supporting people who use substances in acute care settings during the COVID-19 pandemic |
Canadian Research Initiative on Substance Misuse |
Medications and other clinical approaches to support physical distancing for people who use substances during the COVID-19 pandemic |
Canadian Research Initiative on Substance Misuse |
Strategies to Reduce SARS-CoV-2 Transmission in Supportive Recovery Programs and Residential Addiction Treatment Services |
Canadian Research Initiative on Substance Misuse |
Harm reduction worker safety during the COVID-19 global pandemic |
Canadian Research Initiative on Substance Misuse |
COVID-19 Pandemic — National Rapid Guidance |
Canadian Research Initiative in Substance Misuse |
Supporting people who use substances in shelter settings during the COVID‑19 pandemic |
Canadian Research Initiative on Substance Misuse |
Telemedicine support for addiction services |
Canadian Research Initiative on Substance Misuse |
COVID-19 - Opioid Agonist Treatment Guidance |
Canadian Society of Addiction Medicine |
COVID -19: Opioid Agonist Treatment Guidance |
Centre for Addiction and Mental Health |
Addressing a dual public health emergency: supporting physicians to prescribe opioid medications |
CMAJ |
COVID-19 vaccination among people who inject drugs: Leaving no one behind |
Drug and Alcohol Review |
Cannabis and COVID-19 |
First Nations Health Authority |
Alcohol Use: Risk Mitigation Strategies During a Pandemic |
First Nations Health Authority |
Substance Use – Harm Reduction and COVID-19 |
First Nations Health Authority |
Resources for Safer Gambling During COVID-19 |
Gambling Research Exchange Ontario |
COVID-19 – Supporting People Requiring Opioid Dependence Treatment (ODT) |
Government of Newfoundland and Labrador |
Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic |
Harm Reduction Journal |
CDSA Exemption and Interpretive Guide for Controlled Substances |
Health Canada |
Exceptional importation & sale of drugs in relation to COVID-19: Tier 3 drug shortages |
Health Canada |
Frequently Asked Questions: Subsection 56(1) Class Exemption for Patients, Practitioners and Pharmacists Prescribing and Providing Controlled Substances in Canada during the Coronavirus Pandemic |
Health Canada |
Provincial/Territorial Class Exemptions for Supervised Consumption Site Operators |
Health Canada |
Subsection 56(1) class exemption for patients, practitioners and pharmacists prescribing and providing controlled substances in Canada during the coronavirus pandemic |
Health Canada |
Overdose Safety and Support During the Coronavirus Outbreak |
Homeless Services Association of B.C. |
Essential work, precarious labour: The need for safer and equitable harm reduction work in the era of COVID-19 |
International Journal of Drug Policy |
A commentary on the impact of COVID-19 on engagement of youth with substance use and co-occurring psychiatric disorders |
Journal of Substance Abuse Treatment |
Youth OUD treatment during and after COVID: Increasing family involvement across the services continuum |
Journal of Substance Abuse Treatment |
“I have to be around people that are doing what I'm doing”: The importance of expanding the peer recovery coach role in treatment of opioid use disorder in the face of COVID-19 health disparities |
Journal of Substance Abuse Treatment |
Business Not as Usual - Covid-19 Vaccination in Persons with Substance Use Disorders |
New England Journal of Medicine |
Statement by the UN expert on the right to health on the protection of people who use drugs during the COVID-19 pandemic |
Office of the High Commissioner of Human Rights, United Nations |
Managing Addiction Recovery in Isolation |
Online Master of Social Work Programs |
Review of opioid risk assessment tools with the growing need for telemedicine |
Pain Management |
Impact of the COVID-19 pandemic on the pharmacological, physical, and psychological treatments of pain: findings from the Chronic Pain & COVID-19 Pan-Canadian Study |
Pain Reports |
Clinical Risk Factors for COVID-19 Among People With Substance Use Disorders |
Psychiatric Services |
Self-care for Healthcare Professionals and Responders to COVID-19 |
Substance Abuse and Mental Health Services Administration |
Take home injectable opioids for opioid use disorder during and after the COVID-19 Pandemic is in urgent need: a case study |
Substance Abuse Treatment, Prevention, and Policy |
A double-edged sword of using opioids and COVID-19: a toxicological view |
Substance Abuse Treatment, Prevention, and Policy |
Suggestions about treatment, care and rehabilitation of people with drug use disorder in the context of the COVID-19 pandemic |
United Nations Office on Drugs and Crime |
Suggestions about treatment, care and rehabilitation of people with drug use disorder in the context of the COVID-19 pandemic |
United Nations Office on Drugs and Crime |
Alcohol and Opioid use in the Time of COVID-19 (webinar summary and link) |
University of British Columbia |
A public health approach to withdrawal management in a pandemic |
Vancouver Coastal Health |
Prescriber Guidelines for Risk Mitigation in the Context of Dual Public Health Emergencies |
Vancouver Coastal Health |
COVID-19 et les approches favorisant l’observance des mesures de précaution et de protection auprès des personnes en situation de vulnérabilité (in French only) |
Institut national d'excellence en santé et en services sociaux |
Le traitement du trouble lié à l’utilisation d'opioïdes (TUO) : version temporaire comprenant les mesures d'exception autorisées par Santé Canada en lien avec al pandémie de la COVID-19 (in french only) |
Collège des médecins du Québec |
COVID-19 (coronavirus) (in French only) |
Institut national de santé publique du Québec |
Soutien clinique et organisationnel en dépendance et itinérance (in French only) |
Institut universitaire sur les dépendances |
La pharmacothérapie de remplacement des substances psychoactives dans le contexte de pandémie de COVID-19 au Québec: Guide clinique à l’intention des prescripteurs (in French only) |
Institut universitaire sur les dépendances (IUD) du CIUSSS du Centre-Sud-de-l’Île-de-Montréal |
COVID-19 (in French only) |
Institut universitaire sur les dépendances et Centre intégré universitaire de santé et de services sociaux du Centre-Sud-de-l'Île-de-Montréal |